AllianceBernstein
VERA icon

AllianceBernstein’s Vera Therapeutics VERA Stock Holding History

AllianceBernstein’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66.6M Buy
1,314,242
+95,585
+8% +$4.12M 0.02% 508
2025
Q4 		$61.7M Buy
1,218,657
+1,166,066
+2,217% +$41.4M 0.02% 559
2025
Q3 		$1.53M Buy
52,591
+61
+0.1% +$1.41K ﹤0.01% 2148
2025
Q2 		$1.24M Buy
52,530
+11,450
+28% +$257K ﹤0.01% 2183
2025
Q1 		$987K Buy
41,080
+730
+2% +$23.5K ﹤0.01% 2253
2024
Q4 		$1.71M Buy
40,350
+800
+2% +$35.4K ﹤0.01% 2046
2024
Q3 		$1.75M Hold
39,550
– – ﹤0.01% 2031
2024
Q2 		$1.43M Hold
39,550
– – ﹤0.01% 2125
2024
Q1 		$1.71M Buy
39,550
+6,870
+21% +$245K ﹤0.01% 2001
2023
Q4 		$503K Sell
32,680
-1,610
-5% -$20.4K ﹤0.01% 2608
2023
Q3 		$470K Hold
34,290
– – ﹤0.01% 2601
2023
Q2 		$550K Buy
+34,290
New +$310K ﹤0.01% 2583

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein's VERA Position: Q1 2026 in Review

AllianceBernstein increased its Vera Therapeutics (VERA) stake by 7.8% in Q1 2026, buying an estimated $4.12M and bringing the position to 1,314,242 shares worth $66.6M. The position accounts for 0.02% of the portfolio, ranked #508.

AllianceBernstein first reported a position in VERA in Q2 2023 and has held it in 12 quarters since. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • AllianceBernstein held 1,314,242 shares of Vera Therapeutics worth $66.6M as of Q1 2026.
  • AllianceBernstein bought 95,585 Vera Therapeutics shares in Q1 2026, an estimated $4.12M.
  • Vera Therapeutics made up 0.02% of AllianceBernstein's portfolio in Q1 2026, its #508 holding.
  • AllianceBernstein first reported a position in Vera Therapeutics in Q2 2023 and has held it in 12 quarters since.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.